{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:37:28Z","timestamp":1790095048985,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bladder cancer (BCa) is one of the most common urological cancers and remains a leading cause of cancer-related mortality worldwide. Bladder cancer is associated with a range of risk factors, with smoking being one of the most significant contributors. In addition to smoking, exposure to certain chemicals, particularly aromatic amines found in industries such as dye, rubber, leather, and textiles, also increases the risk of bladder cancer. In low-and-middle countries with lower Human Development Index (HDI), data on the underlying causes, incident rate, modes of presentation, treatment, and prognosis of bladder cancer remains unclear and often appear to be inadequate. This study aimed to assess the prevalence, mode of presentation, treatment, and risk factors associated with bladder cancer in Johannesburg, South Africa. By examining these factors, the study seeks to identify possible patterns or predisposing factors that contribute to the development and progression of bladder cancer, which could generate insights that could help to reduce the significant morbidity and mortality associated with this cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study analyzed secondary data from 115 patients who were treated in the radiation oncology unit of an academic hospital between January 2010 and December 2020. By reviewing the medical records of these patients, the study aimed to gather comprehensive information on the prevalence of bladder cancer, modes of presentation, treatment approaches, and associated risk factors. Bladder cancer in this study was assessed using a comprehensive analysis of patient data on demographics, risk factors, clinicopathological aspects, and the specific therapies received. A comparison of patients with squamous cell carcinoma (SCC) and transitional cell carcinoma (TCC) of the bladder was conducted as part of this study. This comparison aimed to explore differences in demographic profiles, risk factors, clinicopathological characteristics, and treatment outcomes between these two histological subtypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 115 patients presenting with bladder cancer symptoms were referred to the academic hospital for evaluation and treatment. The incidence rate of bladder cancer was highest among patients with a mean age of 60.7\u2009\u00b1\u200914.9. Males constituted 60.9% of the cases, resulting in a male-to-female ratio of 1.6:1. The most common risk factors associated with bladder cancer complications included smoking, being male, black ethnicity and increasing age.\u00a0Transitional cell carcinoma remained the most prevalent histological subtype at the academic hospital, compared to squamous cell carcinoma (SCC). Patients with transitional cell carcinoma (TCC) were more likely to be older (odds ratio (OR): 1.03, 95% Confidence Interval (CI): 1.01\u20131.06, <jats:italic>p<\/jats:italic>\u2009=\u20090.029), male (OR: 2.60, 95% CI:1.10\u20136.04, <jats:italic>p<\/jats:italic>\u2009=\u20090.030). The study also found that most of the TCC cases were among black patients, though white patients were four times more likely to present with TCC compared to SCC (OR:4.22, 95% CI: 1.43\u201312.48, <jats:italic>p<\/jats:italic>\u2009=\u20090.009).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Bladder cancer is still widespread in LMICs, with lower HDI, with elderly males being at risk. To aggressively prevent mortality and morbidity from bladder cancer, bladder cancer health awareness must be maintained to improving prevention, as well as early detection, management and comprehensive patient care and health services for bladder cancer patients. These findings highlight the importance of targeted screening and prevention strategies for high-risk groups, particularly older males with a history of smoking.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43046-024-00241-3","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T02:17:39Z","timestamp":1730686659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bladder cancer: a retrospective audit at a single radiation oncology unit of an academic hospital in Johannesburg, South Africa"],"prefix":"10.1186","volume":"36","author":[{"given":"Trenton","family":"Oliver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6746-9431","authenticated-orcid":false,"given":"Duvern","family":"Ramiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4898-8754","authenticated-orcid":false,"given":"Daniel","family":"Mmereki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Hugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwatosin A.","family":"Ayeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,4]]},"reference":[{"issue":"1","key":"241_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/iju.13824","volume":"26","author":"D Adeloye","year":"2019","unstructured":"Adeloye D, Harhay MO, Ayepola OO, Dos Santos JPR, David RA, Ogunlana OO, Gadanya M, Osamor VC, Amuta AO, Iweala EE, Auta A, Rebbeck TR. Estimate of the incidence of bladder cancer in Africa: A systematic review and Bayesian meta-analysis. Int J Urol. 2019;26(1):102\u201312. https:\/\/doi.org\/10.1111\/iju.13824.","journal-title":"Int J Urol"},{"issue":"1","key":"241_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol. 2017;71(1):96\u2013108. https:\/\/doi.org\/10.1016\/j.eururo.2016.06.010.","journal-title":"Eur Urol"},{"issue":"3","key":"241_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/aam.aam_48_17","volume":"17","author":"K Bowa","year":"2018","unstructured":"Bowa K, Mulele C, Kachimba J, Manda E, Mapulanga V, Mukosai S. A review of bladder cancer in Sub-Saharan Africa: A different disease, with a distinct presentation, assessment, and treatment. Ann Afr Med. 2018;17(3):99\u2013105. https:\/\/doi.org\/10.4103\/aam.aam_48_17.","journal-title":"Ann Afr Med"},{"key":"241_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JWF, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, Vecchia CL, Shariat S, Lotan Y. Platinum Priority \u2013 Review \u2013 Bladder Cancer Epidemiology and Risk Factors of Urothelial Bladder Cancer. Eur Urol. 2013;63:234\u201341.","journal-title":"Eur Urol"},{"issue":"6","key":"241_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","volume":"74","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, Kiemeney L, Lotan Y, Pang K, Silverman DT, Znaor A, Catto JWF. Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018. Eur Urol. 2018;74(6):784\u201395. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.001.","journal-title":"Eur Urol"},{"key":"241_CR6","doi-asserted-by":"crossref","unstructured":"Dou, W., Ren, Z., Hu, X., Shao, Y., Lia, T., Xiong, S., Liu, J., Yang, W., Ren, P., Wei, Q., Zeng, H., & Li, X. (2020). Whether pelvic radiotherapy increased the risk of secondary bladder cancer? A systematic review and meta-analysis. 1\u201319.","DOI":"10.21203\/rs.3.rs-19477\/v1"},{"issue":"2","key":"241_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1053\/sonc.2001.21961","volume":"28","author":"NG El Mawla","year":"2001","unstructured":"El Mawla NG, El Bolkainy MN, Khaled HM. Bladder cancer in Africa: Update. Semin Oncol. 2001;28(2):174\u20138. https:\/\/doi.org\/10.1053\/sonc.2001.21961.","journal-title":"Semin Oncol"},{"issue":"1","key":"241_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-021-02705-6","volume":"24","author":"M Fu","year":"2022","unstructured":"Fu M, Zhou H, Li Y, Jin H, Liu X. Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study. Arthritis Res Ther. 2022;24(1):1\u20139. https:\/\/doi.org\/10.1186\/s13075-021-02705-6.","journal-title":"Arthritis Res Ther"},{"issue":"17","key":"241_CR9","doi-asserted-by":"publisher","first-page":"vii45","DOI":"10.1093\/annonc\/mdy368","volume":"29","author":"Y Fujisaka","year":"2018","unstructured":"Fujisaka Y. Management of Immune-Related Adverse Events. Annals Oncol. 2018;29(17):vii45. https:\/\/doi.org\/10.1093\/annonc\/mdy368.","journal-title":"Annals Oncol."},{"issue":"6","key":"241_CR10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/bju.13875","volume":"120","author":"AK Greiman","year":"2017","unstructured":"Greiman AK, Rosoff JS, Prasad SM. Association of Human Development Index with global bladder, kidney, prostate and testis cancer incidence and mortality. BJU Int. 2017;120(6):799\u2013807. https:\/\/doi.org\/10.1111\/bju.13875.","journal-title":"BJU Int"},{"issue":"2","key":"241_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1464-410X.1996.09310.x","volume":"78","author":"AE Groeneveld","year":"1996","unstructured":"Groeneveld AE, Marszalek WW, Heyns CF. Bladder cancer in various population groups in the greater Durban area of KwaZulu-Natal. Br J Urol. 1996;78(2):205\u20138. https:\/\/doi.org\/10.1046\/j.1464-410X.1996.09310.x.","journal-title":"Br J Urol"},{"issue":"2","key":"241_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/0970-1591.52916","volume":"25","author":"P Gupta","year":"2009","unstructured":"Gupta P, Jain M, Kapoor R, Muruganandham K, Srivastava A, Mandhani A. Impact of age and gender on the clinicopathological characteristics of bladder cancer. Indian J Urol. 2009;25(2):207\u201310. https:\/\/doi.org\/10.4103\/0970-1591.52916.","journal-title":"Indian J Urol"},{"issue":"1","key":"241_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.2910630102","volume":"63","author":"JM Kaldor","year":"1995","unstructured":"Kaldor JM, Day NE, Kittelmann B, Pettersson F, Langmark F, Pedersen D, Prior P, Neal F, Karjalainen S, Bell J, Choi W, Koch M, Band P, Pompe-Kirn V, Garton C, Staneczek W, Zar\u00e9n B, Stovall M, Boffetta P. Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: A case\u2014control study. Int J Cancer. 1995;63(1):1\u20136. https:\/\/doi.org\/10.1002\/ijc.2910630102.","journal-title":"Int J Cancer"},{"issue":"0","key":"241_CR14","doi-asserted-by":"publisher","first-page":"0","DOI":"10.21608\/mjmr.2023.181521.1246","volume":"0","author":"NN Kamal","year":"2023","unstructured":"Kamal NN, Mahmoud AM, Khalifa MA, Mohammed KH, Hassan EE. Association between smoking and urinary bladder cancer (BC): case control study in Minia, Egypt. Minia J Med Res. 2023;0(0):0\u20130. https:\/\/doi.org\/10.21608\/mjmr.2023.181521.1246.","journal-title":"Minia J Med Res"},{"issue":"5","key":"241_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.euo.2020.08.013","volume":"3","author":"M Koti","year":"2020","unstructured":"Koti M, Ingersoll MA, Gupta S, Lam CM, Li X, Kamat AM, Black PC, Siemens DR. Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. Eur Urol Oncol. 2020;3(5):622\u201330. https:\/\/doi.org\/10.1016\/j.euo.2020.08.013.","journal-title":"Eur Urol Oncol"},{"issue":"73","key":"241_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.abq2630","volume":"7","author":"H Kwon","year":"2022","unstructured":"Kwon H, Schafer JM, Song NJ, Kaneko S, Li A, Xiao T, Ma A, Allen C, Das K, Zhou L, Riesenberg B, Chang Y, Weltge P, Velegraki M, Oh DY, Fong L, Ma Q, Sundi D, Chung D, Li Z. Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer. Sci Immunol. 2022;7(73):1\u201316. https:\/\/doi.org\/10.1126\/sciimmunol.abq2630.","journal-title":"Sci Immunol."},{"key":"241_CR17","unstructured":"Macmillan Cancer Support. (2014). How treatment is planned. 1\u20138. http:\/\/www.macmillan.org.uk\/information-and-support\/treating\/treatment-decisions\/who-will-be-involved-in-my-treatment-decision\/treatment-planning.html#tcm:9-18827"},{"issue":"3","key":"241_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.urolonc.2006.10.002","volume":"25","author":"DS Michaud","year":"2007","unstructured":"Michaud DS. Chronic inflammation and bladder cancer. Urol Oncol. 2007;25(3):260\u20138. https:\/\/doi.org\/10.1016\/j.urolonc.2006.10.002.","journal-title":"Urol Oncol"},{"issue":"8","key":"241_CR19","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895\u2013904. https:\/\/doi.org\/10.1007\/s00345-019-02984-4.","journal-title":"World J Urol"},{"issue":"11","key":"241_CR20","doi-asserted-by":"publisher","first-page":"850","DOI":"10.7196\/SAMJ.2019.v109i11.13827","volume":"109","author":"S Sinha","year":"2019","unstructured":"Sinha S, Jaumdally SZ, John J, Pinto G, Sinha S, Lazarus J. One-stop haematuria clinic: First experience in South Africa. S Afr Med J. 2019;109(11):850\u20133. https:\/\/doi.org\/10.7196\/SAMJ.2019.v109i11.13827.","journal-title":"S Afr Med J"},{"issue":"3","key":"241_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin."},{"key":"241_CR22","unstructured":"U.S. Department of Health and Human Services. (2010). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease. In How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General."},{"issue":"4","key":"241_CR23","first-page":"681","volume":"10","author":"P Yavari","year":"2009","unstructured":"Yavari P, Sadrolhefazi B, Mohagheghi MA, Mehrazin R. A descriptive retrospective study of bladder cancer at a hospital in Iran (1973\u20132003). Asian Pac J Cancer Prev. 2009;10(4):681\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"241_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1158\/1055-9965.EPI-11-0589","volume":"21","author":"YL Zheng","year":"2012","unstructured":"Zheng YL, Amr S, Saleh DA, Dash C, Ezzat S, Mikhail NN, Gouda I, Loay I, Hifnawy T, Abdel-Hamid M, Khaled H, Wolpert B, Abdel-Aziz MA, Loffredo CA. Urinary bladder cancer risk factors in Egypt: A multicenter case-control study. Cancer Epidemiol Biomark Prev. 2012;21(3):537\u201346. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-0589.","journal-title":"Cancer Epidemiol Biomark Prev"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-024-00241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-024-00241-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-024-00241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T02:18:46Z","timestamp":1730686726000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-024-00241-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["241"],"URL":"https:\/\/doi.org\/10.1186\/s43046-024-00241-3","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,4]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of the Witwatersrand's Human Research Ethics Committee (Wits HREC) (Medical) of our institution issued approval for this study with the number M211024. All patients gave their consent prior to involve in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all involving patients for publication of accompanying data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}